Fetal Hypoxia Clinical Trial
Official title:
Doppler Echocardiography Assessment of Cardiac Sparing Effect in Fetal Hypoxia
NCT number | NCT03146507 |
Other study ID # | AU03 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2017 |
Est. completion date | September 1, 2022 |
Verified date | November 2022 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The fetal heart plays a central role in the adaptive mechanisms for hypoxemia and placental insufficiency. Longitudinal data on the hemodynamic sequence of the natural history of fetal growth restriction show that the umbilical artery and middle cerebral artery are the first variables to become abnormal . These arterial Doppler abnormalities are followed by abnormalities in the right cardiac diastolic indices, followed by the right cardiac systolic indices, and finally by both left diastolic and systolic cardiac indices . Preserving the left systolic function as the last variable to become abnormal ensures an adequate left ventricular output , which supplies the cerebral and coronary circulations.This defence is contingent on the fetal cardiovascular system, which in late gestation adopts strategies to decrease oxygen consumption and redistribute the cardiac output away from peripheral vascular beds and towards essential circulations, such as those perfusing the brain. Adding cardiac Doppler may improve management of the IUGR fetus(intrauterine growth retardation), Doppler ultrasound is valuable in defining the degree of cardiovascular compromise in at-risk pregnancies. The severity of fetal blood flow redistribution shows the degree of fetal adaptation and provides information on how long the pregnancy can be continued safely. The aime of the study is assessment of cardiac output redistribution in fetal hypoxia by estimating relative right to left side cardiac output wich reflect cardiac sparing in (IUGR).
Status | Completed |
Enrollment | 210 |
Est. completion date | September 1, 2022 |
Est. primary completion date | May 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 35 Years |
Eligibility | Inclusion Criteria: 1. Women aged 20-35 years. 2. Women with BMI from 20-30 kg/m2. 3. Pregnant women in singleton fetuses from 32 to 34 weeks gestation. 4. Women with late fetal growth restriction fetuses. It refers to an estimated fetal weight or abdominal circumference <10th centile. Those women had increased the resistant index (RI) in umbilical arteries above the 95th percentile at the time of recruitment (case group). 5. Normal pregnant women (control group). Exclusion Criteria: 1. Women with estimated fetal weight below the 5th or 3rd percentile. 2. Women with premature pre-labor rupture of membranes. 3. Women with antepartum hemorrhage 4. Women with fetal congenital anomalies. 5. Women with absent or reversed diastolic flow in the umbilical artery at the time of recruitment. 6. Women with preeclampsia or on anti-coagulant thereby. 7. Women who refused to participate in our study. |
Country | Name | City | State |
---|---|---|---|
Egypt | Advanced Fetal Cair Unit - Assiut University | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The relative cardiac output ratio (ratio between right side cardiac outputs to left side) cardiac output) at 32-34 weeks. | 1 month | ||
Secondary | The relative cardiac output ratio at 34-36 weeks. | 1 month | ||
Secondary | The pulsatility index in the umbilical artery and middle cerebral artery at 32-34 weeks | 1 month | ||
Secondary | The pulsatility index in the umbilical artery and middle cerebral artery at 34-36 weeks | 1 month | ||
Secondary | Middle cerebral artery pulsatility index to umbilical artery pulsatility index ratio | 15 minutes | ||
Secondary | Time of delivery (weeks) | 7 weeks | ||
Secondary | Birth weight (grams) | 7 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A | |
Active, not recruiting |
NCT00189007 -
Antenatal Allopurinol During Fetal Hypoxia
|
Phase 3 | |
Recruiting |
NCT05681624 -
Maternal Oxygen Supplementation for Intrauterine Resuscitation
|
N/A | |
Completed |
NCT03108040 -
Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction
|
||
Completed |
NCT02377817 -
Halifax PrenaBelt Trial
|
N/A | |
Active, not recruiting |
NCT02643108 -
Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women
|
N/A | |
Completed |
NCT02741284 -
Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings
|
N/A | |
Terminated |
NCT05147584 -
Trans-abdominal Fetal Pulse Oximetry
|
N/A | |
Recruiting |
NCT01533701 -
Scalp Sampling for Fetal Surveillance
|
N/A | |
Terminated |
NCT04437407 -
UniSA BackOff! Study: Adelaide PrenaBelt Trial
|
N/A | |
Not yet recruiting |
NCT03930277 -
Intra-uterine Fetal Brain Activity Monitoring.
|
||
Recruiting |
NCT04876846 -
Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity
|
N/A | |
Recruiting |
NCT06405984 -
Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE
|
Early Phase 1 | |
Suspended |
NCT04364308 -
The Relationship Between Umbilical Cord ph and Feto-maternal Doppler Studies in Scheduled Nonlaboring Term Singleton Caesarean Deliveries
|